ClassID:

94695

C07D265/18 - CPC Classification

Classification description:

Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms 1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2

Recent Application in this class:
#1
20250320184
2025-10-16

SARM1 MODULATORS, PREPARATIONS, AND USES THEREOF

#2
20250228778
2025-07-17

PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THEANINE DISSOLUTION

#3
20240287058
2024-08-29

PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF

#4
20230416262
2023-12-28

TRPML MODULATORS

#5
20230399303
2023-12-14

Macrophage Migration Inhibitory Factor Inhibitors, and Methods of Making and Using Same

#6
20230263805
2023-08-24

DEUTERATED ANALOGS OF ETIFOXINE, THEIR DERIVATIVES AND USES THEREOF

#7
20230054304
2023-02-23

COMPOUND HAVING NEUROPROTECTIVE EFFECT, PREPARATION METHOD THEREFOR AND USE THEREOF

#8
20210177758
2021-06-17

Platform drug delivery system utilizing crystal engineering and theanine dissolution

#9
20200405726
2020-12-31

Deuterated analogs of etifoxine, their derivatives and uses thereof

#10
20190373893
2019-12-12

Plant growth regulator compounds

#11
20190284218
2019-09-19

Carbene precursor compound and use thereof

#12
20190270719
2019-09-05

Deoxyuridine triphosphatase inhibitors

#13
20190015419
2019-01-17

Deuterated analogs of etifoxine, their derivatives and uses thereof

#14
20190000084
2019-01-03

High stress resistant plant growth regulator and preparation method and use thereof

#15
20180155319
2018-06-07

Deoxyuridine triphosphatase inhibitors

#16
20180064717
2018-03-08

Deuterated analogs of etifoxine, their derivatives and uses thereof

#17
20180029975
2018-02-01

Synthesis process for chiral cyclopropyl ethynyl tertiary alcohol compound

#18
20170369481
2017-12-28

Bicyclic PKM2 activators

#19
20170057937
2017-03-02

Process for the preparation of efavirenz and devices suitable therefore

#20
20170008861
2017-01-12

Process for the preparation of Efavirenz using keton solvents

#21
20160347725
2016-12-01

Inhibitors of paxillin function and related compositions and methods

#22
20160326101
2016-11-10

Process for the Synthesis of Chiral Propargylic Alcohols

#23
20160297767
2016-10-13

Estrogen receptor modulators and uses thereof

#24
20160280697
2016-09-29

THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USE

#25
20160039788
2016-02-11

Deoxyuridine triphosphatase inhibitors

#26
20150366871
2015-12-24

Increased dosage of efavirenz for the treatment of cancer

#27
20150307518
2015-10-29

Spirocyclic dihydro-thiazine and dihydro-oxazine BACE inhibitors, and compositions and uses thereof

#28
20150191438
2015-07-09

Preparation and pharmaceuticals of biphenyl benzamide-derived derivatives

#29
20140179694
2014-06-26

Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia

#30
20140088095
2014-03-27

Method for treating pain, anxiety or depression using carbamoyloxy alkanoyl piperazine compound

#31
20140011804
2014-01-09

Bicyclic PKM2 activators

#32
20130281444
2013-10-24

Preparation and pharmaceuticals of biphenyl benzamide-derived derivatives

#33
20130261112
2013-10-03

Cyclothiocarbamate derivatives as progesterone receptor modulators

#34
20130231333
2013-09-05

Estrogen receptor modulators and uses thereof

#35
20130217875
2013-08-22

Process for the synthesis of cyclic carbamates

#36
20130211077
2013-08-15

Process for the synthesis of cyclic carbamates

#37
20130165650
2013-06-27

PROCESS FOR THE PREPARATION OF EFAVIRENZ

#38
20130012561
2013-01-10

Estrogen receptor modulators and uses thereof

#39
20120289471
2012-11-15

NOVEL COMPOUNDS WITH HIGH THERAPEUTIC INDEX

#40
20120271047
2012-10-25

Polymorphs of efavirenz

#41
20120264933
2012-10-18

Efficient process to induce enantioselectivity in procarbonyl compounds

#42
20120245155
2012-09-27

FUSED HETEROCYCLIC COMPOUND HAVING AMINO GROUP

#43
20120232069
2012-09-13

Process for preparing efavirenz polymorph

#44
20120190675
2012-07-26

Azaspirohexanones

#45
20120115858
2012-05-10

Polymorph Form II of Tanaproget

#46
20120115857
2012-05-10

Polymorphs of efavirenz

#47
20120108809
2012-05-03

Process for preparation of Efavirenz

#48
20120095249
2012-04-19

Methods of making Efavirens and intermediates thereof

#49
20120095007
2012-04-19

Carbamoyloxy arylalkan arylpiperazine analgesics

#50
20120071535
2012-03-22

Estrogen receptor modulators and uses thereof

#51
20120071471
2012-03-22

NOVEL BENZOXAZINONE DERIVATIVES USEFUL FOR THE TREATMENT OF CNS DISORDERS

#52
20120053342
2012-03-01

METHOD FOR MAKING CARBAMATES, UREAS AND ISOCYANATES

#53
20120046462
2012-02-23

PROCESS FOR THE SYNTHESIS OF CHIRAL CYCLIC CARBAMATES

#54
20110262369
2011-10-27

Crystalline, enantiomerically pure salt form of a beta-agonist, and the use thereof as a drug

#55
20110212953
2011-09-01

Polymorph form II of tanaproget

#56
20110196151
2011-08-11

Process for the preparation of Efavirenz

#57
20110195963
2011-08-11

Carbamoyloxy arylalkanoyl arylpiperazine analgesics

#58
20110172419
2011-07-14

PROCESS FOR THE SYNTHESIS OF CYCLIC CARBAMATES

#59
20110112084
2011-05-12

Bicyclic androgen and progesterone receptor modulator compounds and methods

#60
20110077397
2011-03-31

Process for the preparation of Efavirenz

#61
20110071287
2011-03-24

PROCESS FOR THE PREPARATION OF EFAVIRENZ

#62
20110053926
2011-03-03

New Pharmaceutically-Active Compounds for the Treatment of Respiratory Diseases

#63
20110015189
2011-01-20

Methods of making efavirenz and intermediates thereof

#64
20100286408
2010-11-11

Efficient process to induce enantioselectivity in procarbonyl compounds

#65
20100274007
2010-10-28

Process for preparing polymorphic forms of (S)-6-chloro-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one

#66
20100267715
2010-10-21

Process for preparing polymorph form II of tanaproget

#67
20100256362
2010-10-07

Method of producing benzoxazinone-based compound

#68
20100210636
2010-08-19

Benzoxazinone derivative

#69
20100160331
2010-06-24

NOVEL CARBAMOYLOXY ARYLALKAN ARYLPIPERAZINE COMPOUND, PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUND AND METHOD FOR TREATING PAIN, ANXIETY AND DEPRESSION BY ADMINISTERING THE COMPOUND

#70
20100160304
2010-06-24

AROMATIC SULFONE COMPOUND AS ALDOSTERONE RECEPTOR MODULATOR

#71
20100113819
2010-05-06

Method for making carbamates, ureas and isocyanates

#72
20100069489
2010-03-18

L-THREONINE DERIVATIVES OF HIGH THERAPEUTIC INDEX

#73
20100069446
2010-03-18

L-threonine derivatives of high therapeutic index

#74
20100069379
2010-03-18

Bicyclic androgen and progesterone receptor modulator compounds and methods

#75
20100063042
2010-03-11

5-substituted benzoxazines

#76
20100063037
2010-03-11

6-substituted benzoxazines

#77
20100029681
2010-02-04

HETEROCYCLIC COMPOUNDS AS CALCIUM CHANNEL BLOCKERS

#78
20100004481
2010-01-07

L-Threonine derivatives of high therapeutic index

#79
20090281096
2009-11-12

Cyclothiocarbamate derivatives as progesterone receptor modulators

#80
20090203667
2009-08-13

PENTADIENAMIDE DERIVATIVES

#81
20090197878
2009-08-06

SUBSTITUTED BENZO[d][1,3]OXAZIN-2(4H)-ONES AND RELATED DERIVATIVES AND THEIR USES FOR MODULATING THE PROGESTERONE RECEPTOR

#82
20090137577
2009-05-28

HETEROCYCLIC COMPOUNDS

#83
20090111802
2009-04-30

CYCLOCARBAMATE DERIVATIVES AS PROGESTERONE RECEPTOR MODULATORS

#84
20090105236
2009-04-23

NEW PHARMACEUTICALLY-ACTIVE COMPOUNDS FOR THE TREATMENT OF RESPIRATORY DISEASES

#85
20090075991
2009-03-19

DEUTERIUM-ENRICHED EFAVIRENZ

#86
20080146797
2008-06-19

Process for synthesizing heterocyclic compounds

#87
20080070909
2008-03-20

Enantiomerically pure beta agonists, manufacturing and use thereof

#88
20070225281
2007-09-27

6-amino-1,4-dihydro-benzo[][1,3]oxazin-2-ones and analogs useful as progesterone receptor modulators

#89
20070219189
2007-09-20

MIF-inhibitors

#90
20070197520
2007-08-23

Mineralocorticoid receptor modulator compounds, processes for their preparation, and their uses

#91
20070190523
2007-08-16

Method and compositions for identifying anti-hiv therapeutic compounds

#92
20070149510
2007-06-28

Quinazolinone and benzoxazinone derivatives and uses thereof

#93
20070112191
2007-05-17

Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones

#94
20070066583
2007-03-22

Monocyclic and bicyclic compounds and methods of use

#95
20070010489
2007-01-11

Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds

#96
20060287244
2006-12-21

L-Threonine derivatives of high therapeutic index

#97
20060247235
2006-11-02

Polymorph form II of tanaproget

#98
20060241017
2006-10-26

Compounds with high therapeutic index

#99
20060235008
2006-10-19

Novel polymorphs of efavirenz

#100
20060189605
2006-08-24

NEW PHARMACEUTICALLY-ACTIVE COMPOUNDS FOR THE TREATMENT OF RESPIRATORY DISEASES

#101
20060142280
2006-06-29

Cyclothiocarbamate derivatives as progesterone receptor modulators

#102
20060128692
2006-06-15

Non nucleoside reverse transcriptase inhibitors

#103
20060115815
2006-06-01

Method and compositions for identifying anti-hiv therapeutic compounds

#104
20060088933
2006-04-27

Reagents for detecting efavirenz

#105
20060047115
2006-03-02

Synthesis of a benzoxazinone

#106
20060009641
2006-01-12

Crystal forms of (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one

#107
20050288350
2005-12-29

Bicyclic androgen and progesterone receptor modulator compounds and methods

#108
20050239054
2005-10-27

Method and compositions for identifying anti-HIV therapeutic compounds

#109
20050209197
2005-09-22

Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds

#110
20050197320
2005-09-08

Non nucleoside reverse transcriptase inhibitors

#111
20050165001
2005-07-28

Quinazolinone and benzoxazinone derivatives and uses thereof

#112
20050137438
2005-06-23

Carbon-carbon cross coupling catalyzed by transition metals on solid supports

#113
20050085470
2005-04-21

6-amino-1,4-dihydro-benzo[d][1,3] oxazin-2-ones and analogs useful as progesterone receptor modulators